Results of a 2nd comparative review were being noted by Flinn et al. That is a period III randomized Intergroup demo evaluating FC program as opposed to FAMP by itself in 278 individuals getting their initially chemotherapy regimen for B-CLL. Dosages of FC plan were the same as the primary https://quentinp887bnx0.blogsuperapp.com/profile